CEL-SCI Corporation

NYSEAM:CVM Stock Report

Market Cap: US$37.2m

CEL-SCI Management

Management criteria checks 3/4

CEL-SCI's CEO is Geert Kersten, appointed in Jan 1989, has a tenure of 35.83 years. total yearly compensation is $1.03M, comprised of 62% salary and 38% bonuses, including company stock and options. directly owns 1.96% of the company’s shares, worth $728.21K. The average tenure of the management team and the board of directors is 15.1 years and 8.2 years respectively.

Key information

Geert Kersten

Chief executive officer

US$1.0m

Total compensation

CEO salary percentage62.0%
CEO tenure35.8yrs
CEO ownership2.0%
Management average tenure15.1yrs
Board average tenure8.2yrs

Recent management updates

Recent updates

Market Sentiment Around Loss-Making CEL-SCI Corporation (NYSEMKT:CVM)

Apr 29
Market Sentiment Around Loss-Making CEL-SCI Corporation (NYSEMKT:CVM)

We Think CEL-SCI (NYSEMKT:CVM) Can Afford To Drive Business Growth

Mar 01
We Think CEL-SCI (NYSEMKT:CVM) Can Afford To Drive Business Growth

What Does CEL-SCI's (NYSEMKT:CVM) CEO Pay Reveal?

Jan 25
What Does CEL-SCI's (NYSEMKT:CVM) CEO Pay Reveal?

Breakeven On The Horizon For CEL-SCI Corporation (NYSEMKT:CVM)

Dec 21
Breakeven On The Horizon For CEL-SCI Corporation (NYSEMKT:CVM)

CEO Compensation Analysis

How has Geert Kersten's remuneration changed compared to CEL-SCI's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$29m

Mar 31 2024n/an/a

-US$30m

Dec 31 2023n/an/a

-US$31m

Sep 30 2023US$1mUS$637k

-US$32m

Jun 30 2023n/an/a

-US$34m

Mar 31 2023n/an/a

-US$35m

Dec 31 2022n/an/a

-US$37m

Sep 30 2022US$1mUS$616k

-US$38m

Jun 30 2022n/an/a

-US$37m

Mar 31 2022n/an/a

-US$36m

Dec 31 2021n/an/a

-US$37m

Sep 30 2021US$854kUS$580k

-US$37m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$35m

Dec 31 2020n/an/a

-US$33m

Sep 30 2020US$3mUS$756k

-US$30m

Jun 30 2020n/an/a

-US$30m

Mar 31 2020n/an/a

-US$32m

Dec 31 2019n/an/a

-US$29m

Sep 30 2019US$5mUS$511k

-US$22m

Jun 30 2019n/an/a

-US$32m

Mar 31 2019n/an/a

-US$26m

Dec 31 2018n/an/a

-US$24m

Sep 30 2018US$3mUS$558k

-US$32m

Compensation vs Market: Geert's total compensation ($USD1.03M) is above average for companies of similar size in the US market ($USD652.28K).

Compensation vs Earnings: Geert's compensation has been consistent with company performance over the past year.

CEO

Geert Kersten (65 yo)

35.8yrs

Tenure

US$1,027,965

Compensation

Mr. Geert R. Kersten, Esq., has been the Chief Executive Officer at CEL-SCI Corporation since February 1995 and served as its Chief Financial Officer. Mr. Kersten joined CEL-SCI Corporation in 1987. Mr. Ke...

Leadership Team

NamePositionTenureCompensationOwnership
Geert Kersten
CEO, Treasurer & Director35.8yrsUS$1.03m1.96%
$ 728.2k
Patricia Prichep
Chief Financial and Operations Officer & Corporate Secretary30.7yrsUS$516.73k0.39%
$ 145.1k
Eyal Talor
Chief Scientific Officer15.1yrsUS$584.23k0.19%
$ 71.7k
Daniel Zimmerman
Senior Vice President of Research & Cellular Immunology15yrsUS$46.08k0.20%
$ 72.7k
John Cipriano
Senior Vice President of Regulatory Affairs15.1yrsUS$326.53k0.10%
$ 38.2k
Giovanni Selvaggi
Acting Chief Medical Officerless than a yearno datano data

15.1yrs

Average Tenure

73yo

Average Age

Experienced Management: CVM's management team is seasoned and experienced (15.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Geert Kersten
CEO, Treasurer & Director35.9yrsUS$1.03m1.96%
$ 728.2k
Robert Watson
Independent Chairman of the Board6.9yrsUS$135.83k0.040%
$ 14.8k
Mario Gobbo
Directorless than a yearno datano data
Bruno Baillavoine
Independent Director9.4yrsUS$133.33k0.0097%
$ 3.6k

8.2yrs

Average Tenure

69yo

Average Age

Experienced Board: CVM's board of directors are considered experienced (8.2 years average tenure).